Form 4: Arteris CEO Sells 70,000 Shares Under 10b5-1 Plan

Arteris, Inc. President and CEO, Janac K Charles, sold 70,000 shares of common stock for approximately $31.20 per share as part of a pre-arranged trading plan.

Summary

• Janac K Charles, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), disposed of 70,000 shares of common stock.
• The transaction occurred on May 8, 2026, at a weighted average sale price of $31.1998 per share.
• The shares were sold in multiple transactions with prices ranging from $29.19 to $32.07.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Charles on March 5, 2025.
• Following the transaction, Mr. Charles beneficially owns 9,302,052 shares, comprising 196,729 directly, 9,049,071 indirectly through Bayview Legacy, LLC, and 56,252 indirectly through Charles and Lydia Janac Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about immediate sentiment, suggesting a planned financial move rather than a reaction to company-specific news.

Positives

• The transaction was conducted under a pre-arranged 10b5-1 trading plan, indicating a planned sale rather than a reaction to recent events, which can reduce concerns about management's immediate outlook.

Negatives

• A significant insider sale by the President and CEO, Director, and 10% Owner, even if planned, can sometimes be interpreted by the market as a lack of confidence or a move to diversify holdings away from the company's stock.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider sales, particularly by high-ranking executives, are common for various personal financial planning reasons, especially when executed under a Rule 10b5-1 plan. Such plans allow insiders to sell shares at pre-determined times or prices to avoid accusations of trading on material non-public information. While the sale itself is specific to Arteris, Inc., the use of a 10b5-1 plan is a standard practice across industries for managing executive stock holdings.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan by Janac K Charles aligns with best practices for corporate insiders managing their equity holdings, similar to executives at companies like NVIDIA, Intel, or AMD who frequently utilize such plans for diversification and liquidity.

Related Party Transactions

• Janac K Charles holds 9,049,071 shares indirectly through Bayview Legacy, LLC, where he is the manager and deemed to have voting and dispositive power.
• Janac K Charles holds 56,252 shares indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee.

Stakeholder Impact

• Shareholders may observe the CEO's sale and potentially interpret it as a signal, though the 10b5-1 plan context suggests it's not based on new information.
• The company's overall ownership structure remains largely stable, with the CEO retaining a significant beneficial interest.

Key Dates

Recommendation

The insider sale, while significant in volume, was executed under a pre-arranged 10b5-1 plan, which typically signals a planned diversification or liquidity event rather than a reaction to new, negative company developments. Given this context, the filing itself does not provide sufficient new information to warrant a change in investment thesis, suggesting a 'hold' recommendation for existing investors.

Keywords

Arteris Inc, AIP, Insider Sale, Form 4, 10b5-1 Plan, CEO Stock Sale, Semiconductor IP, Network-on-Chip